GLP-1 RAs under development for NASH Semaglutide Semaglutide showed a significant dose-dependent NASH resolution without worsening of fibrosis in a phase 2 randomized controlled trial (RCT) involving patients with NASH and stage 13 fibrosis
Taurine This antioxidant improves energy levels, athletic performance, and reaction time, helping you stay sharp and focused
PPAR is required for placental, cardiac, and adipose tissue development
Finally, all antibiotic resistance may originate from the microbiome, suggesting that solutions might be found by embracing this field
Tirzepatides design deliberately exploits both incretin axes: GLP-1 receptor activation promotes satiety, slows gastric emptying, and enhances glucose-dependent insulin secretion, while GIP receptor engagement appears to amplify insulin responses and may contribute independently to adipose tissue metabolism